CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Genera Biosystems Limited is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Genera Biosystems Limited
1 Dalmore Drive
Phone: +61 397631287p:+61 397631287 Melbourne, VIC  3179  Australia Fax: +61 397632817f:+61 397632817

This company is no longer actively traded on any major stock exchange.

Business Summary
Genera Biosystems Limited is engaged in the development and commercialization of a portfolio of molecular diagnostic test technologies in Australia. The Company is developing a suite of molecular diagnostic testing products based on its AmpaSand bead-based technology. The Company's AmpaSand beads are utilized in its PapType and RTIplex molecular diagnostic tests. It has approximately three additional AmpaSand bead-based multiplexed tests in its development pipeline. PapType is a molecular diagnostic test for the simultaneous detection and genotyping of approximately 14 high-risk and over two low-risk types of human papillomavirus (HPV), the viruses that cause cervical cancer in women and genital warts. RTIplex is an automated assay for the simultaneous detection of approximately 12 viral and over three bacterial respiratory pathogens. The RTIplex kit is used for the detection and identification of over 15 respiratory analytes from nasopharyngeal swab specimens.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
-Yes-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/20186/30/2018Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Scientific Officer, Executive Director Karl F.Poetter 9/25/2007
Chief Executive Officer, Executive Director Richard N.Hannebery 10/2/2014 5/14/2013
Director Corporate Development Seong J.Chen 8/31/2018 8/31/2018
Director Corporate Development – North America GuillermoElias 4/12/2019 4/12/2019
Company Secretary Melanie J.Leydin 1/1/2013 1/1/2013

Business Names
Business Name
GBI
Genera Biosystems Limited

General Information
Number of Employees: 10 (As of 6/30/2012)
Outstanding Shares: 107,466,239 (As of 6/30/2018)
Shareholders: 630
Stock Exchange: ASX
Fax Number: +61 397632817


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 15, 2019